School of Medicine
Showing 1-20 of 96 Results
-
Jennifer Carlson
Clinical Associate Professor, Pediatrics - Adolescent Medicine
Current Research and Scholarly Interests Female athlete triad; adolescents and eating disorders; athletes and supplement use; effects of sports involvement on adolescent self-esteem.
-
Suzan Carmichael
Professor (Research) of Pediatrics (Neonatology), of Obstetrics & Gynecology (Maternal Fetal Medicine) and, by courtesy, of Health Research and Policy (Epidemiology)
Current Research and Scholarly Interests Dr. Carmichael is a perinatal and nutritional epidemiologist and Professor of Pediatrics at the Stanford University School of Medicine. Her research focuses on finding ways to improve maternal and infant health. Exposure themes include nutrition, social context, care, environmental contaminants and genetics. Outcome themes include severe maternal morbidity, stillbirth, birth defects, and preterm delivery. She is particularly interested in understanding the intersectionality of these varied types of exposures and outcomes and how they interact to impact health and health disparities, for the mother-baby dyad.
-
Ricardo Castillo
Associate Professor of Pediatrics (Gastroenterology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly Interests Study of the interaction and role of nutrients and intestinal growth factors in enhancing intestinal adaptation and allograft viability using animal models for short bowel syndrome and orthtopic intestinal transplantation.
Study of immunosuppression regimens and induction of immune tolerance in intestinal transplantation. -
Robert Castro
Clinical Professor, Pediatrics - Neonatal and Developmental Medicine
Current Research and Scholarly Interests Neonatal Fluid Balance
Surfactant
Lung Fluid Reabsorption -
Alma-Martina Cepika
Senior Research Scientist, Pediatrics - Ped Stem Cell Transplantation
Current Role at Stanford As a senior research scientist in the laboratory of Dr. Maria Grazia Roncarolo, Dr. Cepika is working to identify a molecular landscape of inducible type 1 regulatory T cells (Tr1), and how it defines their functions. Tr1 designed to be tolerant specifically to patient tissue are currently investigated in a phase I clinical trial, with an ultimate goal to use Tr1 cell therapy to prevent graft-vs-host disease in patients with hematological cancers undergoing allogeneic hematopoietic stem cell transplantation (NCT03198234). Identifying the components critical for identity of these cells and understanding their mechanism of action is an essential step for harnessing their suppressive power in the clinic.
